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Abstract
Vaccines based on microbial cell surface polysaccharides have long been considered as attractive means to control
infectious diseases. To realize this goal, detailed systematic information about the antigenic polysaccharide is necessary.
However, only a few databases that provide limited knowledge in this area are available. This paper describes PolysacDB, a
manually curated database of antigenic polysaccharides. We collected and compiled comprehensive information from
literature and web resources about antigenic polysaccharides of microbial origin. The current version of the database has
1,554 entries of 149 different antigenic polysaccharides from 347 different microbes. Each entry provides comprehensive
information about an antigenic polysaccharide, i.e., its origin, function, protocols for its conjugation to carriers, antibodies
produced, details of assay systems, specificities of antibodies, proposed epitopes involved and antibody utilities. For
convenience to the user, we have integrated web interface for searching, advanced searching and browsing data in
database. This database will be useful for researchers working on polysaccharide-based vaccines. It is freely available from
the URL: http://crdd.osdd.net/raghava/polysacdb/.
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Introduction
Polysaccharides are composed of repeating units of a single
sugar or an oligosaccharide moiety and may also contain non-
carbohydrate constituents such as lipids or proteins [1–3]. They
are often present on the cell surface of pathogenic microbes and
have vital role in host-pathogen interactions. They are also
excellent immunogens as they produce broad-spectrum immune
responses which may lead to the protection of the host from the
subsequent infection [4]. Hence microbial polysaccharides can be
used to design vaccines to prevent the infectious diseases. In fact, a
polysaccharide vaccine against Streptococcus pneumoniae has been
licensed for use in humans [5]. Furthermore, with the increase in
the incidence of antibiotic resistance which may limit our
therapeutic choices in future, polysaccharide based vaccines could
provide an attractive alternative as they are not modified by
mutations. In this context, a database compiling all the antigenic
polysaccharides becomes an urgent need as it will not only
facilitate in designing newer polysaccharides-based vaccines
against microbial pathogens but also augment our understanding
about the host-pathogen interactions.
In the past, number of databases have been developed for
designing peptide/protein-based vaccines such as IEDB [6],
MHCBN [7], BCIPEP [8], AntiJen [9], PRRDB [10], SYF-
PEITHI [11] etc. Some databases such as IMGT [12] and DIGIT
[13] give comprehensive information on immunoglobulin se-
quences. Previously, we had developed a database HaptenDB
which provided comprehensive information on haptens [14].
Surprisingly, very few computational resources have been created
in the area of carbohydrate/polysaccharide antigens. Immune
Epitope database [IEDB] provides information on non-peptide
epitopes (including carbohydrates) that are found in species
ranging from humans to prokaryotic bacteria. However, this
database does not provide any information on the characteristics
of either antigens or antibodies. In order to provide a service to the
scientific community involved in the development of carbohydrate
or polysaccharides-based vaccines, we have made a systematic
attempt to collect information about antigenic polysaccharides of
microbial origin from literature and web-based resources. This
information has been compiled in a database PolysacDB.
Results and Discussion
This database was constructed mainly to create a resource that
would facilitate easy retrieval of information which is otherwise
scattered in literature. It is for the first time an attempt has been
made to create a comprehensive database on antigenic polysac-
charides of microbial origin. This database tries to bring the
experimental data out into the open in a succinct and consolidated
form. The data curation is completely manual which required
considerable effort and time, as this involved delving deep into
papers and deducing conclusions out of experimental data. We
believe that such manual curation provides greater reliability and
accuracy.
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The data collection was a baseline task for PolysacDB database
and started with defining the full database schema. The data was
collected from three primary sources viz. PubMed, BCSDB
(Bacterial Carbohydrate Structure Database) and IEDB. Initially,
the relevant papers were downloaded using appropriate keywords
such as ‘‘microbe’’, ‘‘polysaccharide’’, ‘‘antibody’’ etc. They were
then carefully scrutinized for relevant information. Only those
papers revealing immunological data about the carbohydrate sub-
structures on microbial cell surface were selected. Emphasis was
especially given, to those where specific antibodies were used or
generated. Papers that were limited in giving information only on
polysaccharide structures or those giving information on polysac-
charides from non-microbial species were removed. Thus among
600 peer-reviewed publications that were accessed, 400 were used
for entering the data into the database. In addition to the
published information, structures were derived from BCSDB
database for a number of polysaccharides. Since each entry was
based on the information derived from physical experiments, we
have divided the information into two basic levels – one level
describing the ‘‘experimental parameters’’ used and the other level
describing the ‘‘results obtained’’. Each entry in the database
includes; i) general information like name, nature and functions of
the polysaccharides; ii) protocols of immunization including carrier
proteins, coupling protocols and assays and iii) name and nature of
the antibodies, their specificities and cross-reactivities, proposed
epitopes involved and antibody utilities. It was strived to give
maximum information on the antibody cross-reactivity profiles
and the epitopes involved. In order to provide comprehensive
information, data in the database is linked to various databases
such as BCSDB and IEDB.
Database Schema, Statistics and Updating
Database statistics: The PolysacDB schema contains 18 unique
fields, overall schema of the database is provided in Figure 1. The
predominantantigenicpolysaccharidesthatproduceantibodieshave
been mainly classified into ‘‘Capsular Polysaccharide’’, ‘‘Lipopoly-
saccharide’’, ‘‘Glycolipids’’ and ‘‘Glycoproteins’’ classes. Such a
classification would help in the general accessibility to the data and
would create a new interface through which a user can search the
database. Figure 2 shows the relative prevalence of these classes in
PolysacDB. It could be seen from Figure 2 that most of the antigenic
polysaccharides fallwithinthe longchainpolysaccharideclassessuch
as ‘‘lipopolysaccharides’’ and ‘‘capsular polysaccharides’’ (74%),
while a small portion falls withinthe ‘‘glycolipid’’ and‘‘glycoprotein’’
classes (26%). This underscores the importance of chain length of a
polysaccharide and the effect it has on its immunogenicity. Since the
data in PolysacDB is purely based on experimental results, it is
reasonable toassumethatadditionalentriesinfuture wouldcontinue
to improve the scope of the database.
Data updating tools
In order to maintain the usefulness of the database in the long
run, it is necessary to create an efficient data updating system so
that users all over the world will be able to add new entries as well
as update the existing entries. In lieu of this, we have prepared a
system that facilitates data updating via two different ways: first
through the ‘‘Online Submission’’ webpage and second through
DrugPedia. The ‘‘Online Submission’’ webpage provides the
interface to add the data in the already prescribed field format in
an intermediate table. The data from intermediate table will be
validated by our team at an interval of two to three months and
stored in main data storage table through a PHP script. DrugPedia
is mainly conceived to facilitate modification of already existing
data within the database. Each record obtained through search or
browse provides links to DrugPedia where users may modify
already existing data by either adding or deleting information.
After proper validation by our expert team, the information from
DrugPedia will be stored to main data storage table of PolysacDB
database.
User Interface
PolysacDB provides simple and user friendly interface to
‘‘search’’ and ‘‘browse’’ data. The ‘‘Search Option’’ allows user
to search data on any field like keywords, microbe, polysaccharide
name etc. Advanced Search option combines two types of queries,
the name of the polysaccharide and the name of the microbe. For
example, advance search on ‘‘lipopolysaccharide’’ (polysaccha-
rides) and ‘‘Vibrio cholerae’’ (microbe) extract 59 entries, each
describes the immunological properties of lipopolysaccharides
present on the surface of V. cholerae. Search option provides a large
number options: i) ‘‘Containing’’ and ‘‘Exact’’ type of search, ii)
option for selecting specific fields to be searched and, iii) option for
selecting specific fields to be displayed. Browse option provides a
powerful interface to retrieve data without entering keywords. A
total of four fields may be browsed directly viz. Polysaccharide
classes, Microbe, Carrier Name and Antibodies. Each field further
leads to the respective list of names that can be browsed to get the
specific entries.
Database utilities
An important utility of PolysacDB is that it can be used as a
resource to investigate antigen-antibody interactions involving
microbial polysaccharides by making use of specificities and
avidities of the respective antibodies. For example, the cross-
reactivity profile of an antibody, generated against a carbohydrate
structure may indicate the presence of a similar structure, a
common epitope, in two different species. For example, in the
entries observed via the browse option within the E. coli O18A field,
one can find that on immunizing mice with boiled E. coli O18A
bacteria, antibodies with three types of specificities were obtained.
One type reacted with only the homologous E. coli sps., the second
type was cross-reactive with other E. coli sps. While the third type,
although specific to the homologous species, also cross-reacted
with S. marcescens 08 LPS. The epitope of the latter type of
antibodies was found out to be N-acetyl-D-glucosamine. This may
implicate that a structure similar to N-acetyl-D-glucosamine exists
on the surface of S. marcescens [15]. Hence the database may be
utilized to predict the cross-reactivity of anti-polysaccharide
antibodies with particular microbes, based on the presence of
similar polysaccharide epitopes. In other words, the database
would be useful in predicting novel epitopes on polysacchaide
backbones of different microbial species
PolysacDB gives information on the structures and functions of
polysaccharides that are usually involved in basic house-keeping
and virulence-associated functions within the microbe. It gives
information on the methodologies used to conjugate polysaccha-
rides to appropriate carriers for immunization purposes. Such
protocols often dictate the nature of antibodies produced against
a particular immunogen. It is also worthwhile to note that the
majority of anti-polysaccharide antibodies have been produced
using whole bacterial cells as immunizing material. A field
describing the assay systems, such as ELISA, western blotting,
immunofluorescence etc used for characterizing the antibodies is
given. The epitopes involved have been enumerated and links to
IEDB have been given wherever applicable. Since the surface
polysaccharides play a vital role in the virulence of pathogens, the
antibodies against these are often found to be protective and
PolysacDB
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reagents. The database provides information on these aspects in
the antibody utility fields. PolysacDB also provides a platform
that would facilitate users to order or request for procurement of
antibodies from different organizations/sources.
Limitations and future prospects
We have observed that information on antigenic polysaccha-
rides is quite abundant, but scattered. Further literature search is
required to expand the database and make it more comprehensive.
Also, some of the data may seem redundant since many
Figure 1. The complete database architecture showing its various components.
doi:10.1371/journal.pone.0034613.g001
Figure 2. Relative prevalence of the various types of polysaccharides within PolysacDB.
doi:10.1371/journal.pone.0034613.g002
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but when we see the cross-reactivity and epitope fields of
individual entries, it becomes clear that the entries are entirely
different. From technical point of view, it is very difficult to
maintain the quality of data since lots of special symbols are there
in carbohydrate names and structures that creates problems while
storing data in MySQL, though enough care was taken during
data storage but still some efforts are required for proper data
storage and display. In near future, we are hopeful of expanding
the database both qualitatively as well as quantitatively to cover
more information. The database will be further updated manually
on a regular basis.
Conclusions
PolysacDB provides online web tools that allow the users to
retrieve and analyze the data. It includes tools: (1) for searching
database using keywords with many options and (2) for browsing
the database on polysaccharide names and microbes. It also shows
specific details on aspects such as structure and functions of the
polysaccharides, conjugation protocols to carriers and character-
istics and utilities of the antibodies. In addition, it provides internal
hyperlinks to display detailed information and external hyperlinks
to other databases. In future, PolysacDB will be further improved
by providing detailed two-dimensional structures of polysaccha-
rides along with the spatial conformation and location of the
epitopes within such structures. We believe that PolysacDB will
facilitate the open source knowledge distribution of polysaccharide
antigens and contribute to more detailed understanding of their
immunogenicity and antigenicity.
Materials and Methods
Web Interface and Application
The whole database is running under LAMP (Linux-Apache-
Mysql-PHP) Server technology, integration of four open source
softwares. PHP, HTML and CSS technologies have been used to
build the dynamic web interface. MySQL, a relational database
management system (RDBMS), works at the backend and
provides commands to retrieve stored antigenic carbohydrate
data. PHP, a server side scripting language, provides interface and
functions to fetch data from database. The whole software system
runs on IBM SAS x3800 machine under Red Hat Enterprise
Linux 5 environment using Apache httpd server. PHP and
MySQL combination is quite efficient and powerful for database
management.
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